Search | TVST | ARVO Journals

Showing 1 – 20 of 47

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2023

Visual Outcomes and Incidence of Complications after Vitrectomy for Vitreous Hemorrhage Associated with Retinal Vein Occlusion

Ankur Nahar; Taku Wakabayashi; Neil Patel; Matthew Bough; Young Sheng; Mirataollah Salabati; Raziyeh Mahmoudzadeh; Ajay E. Kuriyan; Arunan Sivalingam; Yoshihiro Yonekawa

Invest. Ophthalmol. Vis. Sci.. 2023; 64(8):OD83.

Retina February 2023

Myo/Nog Cells Give Rise to Myofibroblasts During Epiretinal Membrane Formation in a Mouse Model of Proliferative Vitreoretinopathy

PDF

Mara Crispin; Jacquelyn Gerhart; Alison Heffer; Mark Martin; Fathma Abdalla; Arturo Bravo-Nuevo; Nancy J. Philp; Ajay E. Kuriyan; Mindy George-Weinstein
TAGS: antibodies, epiretinal membrane, eye, mice, myofibroblasts, retina, vitreoretinopathy, proliferative, muscle proteins, vitreous body, leukocytes
Invest. Ophthalmol. Vis. Sci.. 2023; 64(2):1. https://doi.org/10.1167/iovs.64.2.1

ARVO Annual Meeting Abstract June 2022

Racial and Gender Disparities in Enrollment and Participation in Diabetic Macular Edema Clinical Trials in the United States

Ajay E. Kuriyan; Theo Bowe; Rebecca Russ Soares; Charles Huang; Rishi P Singh; M. Ali Ali Khan; Basil K Williams; Jayanth Sridhar; Allen Chiang; Michael Cohen; Michael Klufas; Omesh P Gupta; Yoshihiro Yonekawa; David Xu

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2505 – F0231.

ARVO Annual Meeting Abstract June 2022

Clinical Outcomes of Patients with Endophthalmitis after Dexamethasone Intravitreal Implant

Annika G. Samuelson; Ankur Nahar; Samir N Patel; Raziyeh Mahmoudzadeh; Mirataollah Salabati; JOHN W HINKLE; Rebecca Russ Soares; Ajay E. Kuriyan; Sunir Garg

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):4299.

ARVO Annual Meeting Abstract June 2022

Outcomes of Retinectomy without Lensectomy in Eyes with Rhegmatogenous Retinal Detachments with Proliferative Vitreoretinopathy

Raziyeh Mahmoudzadeh; Nikita Mokhashi; Shail Patel; Hannah Anderson; Mirataollah Salabati; Allen Chiang; Ajay E. Kuriyan; Omesh P Gupta; Sonia Mehta; Sunir Garg; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3468 – F0368.

ARVO Annual Meeting Abstract June 2022

Refractive Error Change During Diabetic Macular Edema Treatment: A Post Hoc Analysis of the DRCR Protocol T Trial

Mirataollah Salabati; Raziyeh Mahmoudzadeh; Matthew Starr; Qiang (Ed) Zhang; James Sharpe; Jason Hsu; Allen C Ho; Carl Regillo; Ajay E. Kuriyan

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):2188 – F0251.

ARVO Annual Meeting Abstract June 2021

Inhibition of TNF-α and NF-κB decreases epithelial-mesenchymal transition in cigarette smoke-induced proliferative vitreoretinopathy

Victor Wang; Alison Heffer; Elisa Roztocil; Steven E Feldon; Collynn Woeller; Ajay E. Kuriyan

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3644.

ARVO Annual Meeting Abstract June 2021

Intravitreal HC-HA/PTX3, a soluble matrix component of amniotic membrane, inhibits proliferative vitreoretinopathy (PVR) in a mouse model of PVR

Ajay E. Kuriyan; Alison Heffer; Victor Wang; Hua He; Megha Mahabole; Steven E Feldon; Richard T Libby; Scheffer C G Tseng; Collynn Woeller

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3095.

ARVO Annual Meeting Abstract June 2021

Retinal Displacement Following Incisional Rhegmatogenous Retinal Detachment Repair

Raziyeh Mahmoudzadeh; Mirataollah Salabati; Yoshihiro Yonekawa; Ajay E Kuriyan; M.Ali Khan; Michael A. Klufas; Sunir J. Garg; Omesh Gupta; Carl Regillo; Michael N. Cohen

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3084.

ARVO Annual Meeting Abstract June 2021

Effect of Taping Face Masks on Quantitative Particle Counts Near the Eye: Implications for Intravitreal Injections in the COVID-19 Era

William Schultheis; James Sharpe; Qiang (Ed) Zhang; Samir Patel; Ajay E Kuriyan; Allen Chiang; Sunir J. Garg; Jason Hsu

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1363.

ARVO Annual Meeting Abstract June 2020

Update on “Cell Therapy” Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States

Adam Ross-Hirsch; Matthew Nicholas; Rajinder Nirwan; Thomas Albini; Jayanth Sridhar; Harry W Flynn; Ajay E. Kuriyan

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):802.

ARVO Annual Meeting Abstract June 2020

Factors associated with visual outcomes and treatment discontinuation in eyes with retinal vein occlusion and macular edema in real-world settings

Therlinder Lo; Daniella Lent-Schochet; Kieu-Yen Luu; Ajay E. Kuriyan; Menachem Y. Weiss; Aleksandra Rachitskaya; Rishi P Singh; Karen Michelle Wai; J. Peter Campbell; Kishan Gupta; Eric Nudleman; Kevin C. Chen; Glenn Yiu

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1314.

ARVO Annual Meeting Abstract June 2020

A novel mouse model of proliferative vitreoretinopathy induced by intravitreal injection of gas and RPE cells.

Ajay E. Kuriyan; Alison Heffer; Victor Wang; Jayanth Sridhar; Steven E Feldon; Richard T Libby; Collynn Woeller

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1410.

ARVO Annual Meeting Abstract June 2020

TNF-α plays a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy

Victor Wang; Alison Heffer; Steven E Feldon; Richard T Libby; Collynn Woeller; Ajay E. Kuriyan

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1412.

ARVO Annual Meeting Abstract June 2020

Refractive outcomes of anterior chamber intraocular lens implantation

Bailey M Harrison; Sana Idrees; David DiLoreto, Jr; Mina Chung; Rajeev Ramchandran; Ajay E. Kuriyan

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1683.

ARVO Annual Meeting Abstract June 2020

Development of HC-HA/PTX3 as a Biologic for Proliferative Vitreoretinopathy (PVR) Treatment

Hua He; Ajay E. Kuriyan; Esdras Arrieta; Megha Mahabole; Yuan Zhang; Kristy Hamlin; Victoria Graham; Jean-Marie A Parel; Harry W Flynn; Scheffer C.G. Tseng

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3061.

ARVO Annual Meeting Abstract June 2020

Postoperative outcomes of primary rhegmatogenous retinal detachment repairs at an academic medical center

Sai Nimmagadda; Matthew Nicholas; David Diloreto; Mina Chung; Rajeev Ramchandran; David Maxwell Kleinman; Ajay E. Kuriyan

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3749.

ARVO Annual Meeting Abstract June 2020

Automated vessel density detection in fluorescein angiography images correlates with vision in proliferative diabetic retinopathy

Rajeev Ramchandran; Mohammad H Bawany; Li Ding; Gaurav Sharma; Charles Clifton Wykoff; Ajay E. Kuriyan

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5312.

Articles June 2020

A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells

PDF

Alison Heffer; Victor Wang; Jayanth Sridhar; Steven E. Feldon; Richard T. Libby; Collynn F. Woeller; Ajay E. Kuriyan
TAGS: injections, intravitreal injections, mice, retinal pigment cell, vitreoretinopathy, proliferative, eye, vitreous body, retina, tissue membrane
Trans. Vis. Sci. Tech.. 2020; 9(7):9. https://doi.org/10.1167/tvst.9.7.9

ARVO Annual Meeting Abstract July 2019

Assessing the level of evidence for the benefit of commercially-available “cell therapy” treatments in the U.S. for ocular diseases

Andrew Chen; Daniel Simhaee; Rajinder Singh Nirwan; Thomas A Albini; Jayanth Sridhar; Harry Flynn; Ajay E. Kuriyan

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):6400.

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Visual Outcomes and Incidence of Complications after Vitrectomy for Vitreous Hemorrhage Associated with Retinal Vein Occlusion

Myo/Nog Cells Give Rise to Myofibroblasts During Epiretinal Membrane Formation in a Mouse Model of Proliferative Vitreoretinopathy

Racial and Gender Disparities in Enrollment and Participation in Diabetic Macular Edema Clinical Trials in the United States

Clinical Outcomes of Patients with Endophthalmitis after Dexamethasone Intravitreal Implant

Outcomes of Retinectomy without Lensectomy in Eyes with Rhegmatogenous Retinal Detachments with Proliferative Vitreoretinopathy

Refractive Error Change During Diabetic Macular Edema Treatment: A Post Hoc Analysis of the DRCR Protocol T Trial

Inhibition of TNF-α and NF-κB decreases epithelial-mesenchymal transition in cigarette smoke-induced proliferative vitreoretinopathy

Intravitreal HC-HA/PTX3, a soluble matrix component of amniotic membrane, inhibits proliferative vitreoretinopathy (PVR) in a mouse model of PVR

Retinal Displacement Following Incisional Rhegmatogenous Retinal Detachment Repair

Effect of Taping Face Masks on Quantitative Particle Counts Near the Eye: Implications for Intravitreal Injections in the COVID-19 Era

Update on “Cell Therapy” Clinics Offering Treatments of Ocular Conditions using Direct-to-Consumer Marketing Websites in the United States

Factors associated with visual outcomes and treatment discontinuation in eyes with retinal vein occlusion and macular edema in real-world settings

A novel mouse model of proliferative vitreoretinopathy induced by intravitreal injection of gas and RPE cells.

TNF-α plays a critical role in cigarette smoke-induced epithelial-mesenchymal transition of retinal pigment epithelial cells in proliferative vitreoretinopathy

Refractive outcomes of anterior chamber intraocular lens implantation

Development of HC-HA/PTX3 as a Biologic for Proliferative Vitreoretinopathy (PVR) Treatment

Postoperative outcomes of primary rhegmatogenous retinal detachment repairs at an academic medical center

Automated vessel density detection in fluorescein angiography images correlates with vision in proliferative diabetic retinopathy

A Mouse Model of Proliferative Vitreoretinopathy Induced by Intravitreal Injection of Gas and RPE Cells

Assessing the level of evidence for the benefit of commercially-available “cell therapy” treatments in the U.S. for ocular diseases

To View More...

You must be signed into an individual account to use this feature.